4479 |
Prognostic Impact of Mildly Impaired Renal Function After Multivessel Revascularization |
Taeoh Kim |
Apr. 20. 23 |
4478 |
Racial Differences of Prosthesis-Patient Mismatch After TAVR |
Hanbit Park |
Apr. 20. 23 |
4477 |
Inter-Racial Differences in Characteristics and Outcomes After TAVR: TP-TAVR Registry |
Do-Yoon Kang |
Apr. 20. 23 |
4476 |
Is TEVAR Safe and Durable in Long Term? |
Ju Han Kim |
Apr. 20. 23 |
4475 |
Is EVAR Safe and Durable in Long Term? |
Young-Guk Ko |
Apr. 20. 23 |
4474 |
Recent Updates of Long-term Outcomes After Surgical/Endovascular AAA Repair |
Ki-Hyun Jeon |
Apr. 20. 23 |
4473 |
My 30 Years Story - Caring for Patients With Symptomatic Vascular Disease |
John Robert Laird, Jr. |
Apr. 20. 23 |
4472 |
A Multi Center Analysis on Safety and Efficacy of BTK Everolimus-Eluting Stent from Taiwan |
Jen-Kuang Lee |
Apr. 20. 23 |
4471 |
Selection of Guidewires and Supporting Devices for BTK Interventions |
Jae-Hwan Lee |
Apr. 20. 23 |
4470 |
How I Manage Long Femoropopliteal Artery CTOs with EVT |
Chul-Min Ahn |
Apr. 20. 23 |